28/07/2014 20:36:31 Free Membership Login

   

Achillion Pharmaceuticals, Inc.

Visual Financials
Company Name: Achillion Pharmaceuticals, Inc.
Ticker Symbol: ACHN
WWW Address: http://www.achillion.com
CEO: Milind Deshpande
No. of Employees: 57
Common Issue Type: CS
Business Description:Achillion Pharmaceuticals, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative treatments for infectious diseases.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 7.07 Down -0.15 6.99 7.08 7.21 7.30 7.03 2111493
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 684.3 96.8 0.00 -0.63 0.00 0.0 0.0 8.61 - 2.26
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close7.07$
PE Ratio - LTM0.0
Market Capitalisation684.3mil
Latest Shares Outstanding96.8mil
Earnings pS (EPS)-0.63$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee$
Effective Tax Rate0.0%
Float56.4mil
Float as % of Shares Outstanding0.6%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.00%
Research & Devlopment (R&D) as % of Revenue0.00%
Gross Profit Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Assets Turnover0.0%
Return on Assets (ROA)-48.3%
Return on Equity (ROE)-52.4%
Return on Capital Invested (ROCI)-52.1%
Current Ratio13.3
Leverage Ratio (Assets/Equity)1.1
Interest Cover-1132.6
Total Debt/Equity (Gearing Ratio)0.00
LT Debt/Total Capital0.0%
Working Capital pS1.19$
Cash pS0.00$
Book-Value pS1.43$
Tangible Book-Value pS1.58$
Cash Flow pS-0.56$
Free Cash Flow pS-0.56$
KEY FIGURES (LTM): Price info
Price/Book Ratio5.05
Price/Tangible Book Ratio0.00
Price/Cash Flow-13.0
Price/Free Cash Flow-12.9
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---7.672,752,8282,098,324
4 Weeks7.966.607.57-4.6-63,108,95262,179,049
13 Weeks8.612.452.73164.51596,271,883401,400,532
26 Weeks8.612.453.43110.5994,022,448510,850,943
52 Weeks8.612.266.914.6-133,213,174809,719,941
YTD8.612.45-119.51113,890,626556,359,561
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
7.076.955.974.193.840.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.0
Income0.0
Dividend0.0
Capital SpendingNA
R&D11.48NA28.43
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %-100.0-100.0955.5
Earnings %0.00.00.0
EPS %0.00.00.0
EPS $-0.01-0.010.05
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio71.04
Current Ratio13.3
Quick Ratio (Acid Test)13.1
Liquidity Ratio (Cash)16.52
Receivables Turnover0.0
Average Collection Period
Working Capital/Equity75.4
Working Capital pS1.19
Cash-Flow pS-0.57
Free Cash-Flow pS-0.58
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio43.48
Financial Leverage Ratio (Assets/Equity)0.0
Debt Ratio0.2
Total Debt/Equity (Gearing Ratio)0.00
LT Debt/Equity0.00
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities16.1
Interest Cover-1132.6
Interest/Capital Invested0.03
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio4.30
Current P/E Ratio - LTM0.00
Enterprise Value (EV)/EBITDA-9.45
Enterprise Value (EV)/Free Cash Flow-10.06
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM5.05
Price/Cash Flow Ratio-13.0
Price/Free Cash Flow Ratio - LTM-12.9
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio-19.8
5-Y Low P/E Ratio-2.1
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS0.00
Current Liabilities pS0.17
Tangible Book Value pS - LTM1.58
Book Value pS - LTM1.43
Capital Invested pS1.58
Cash pS - LTM0.00
Cash Flow pS - LTM-0.56
Free Cash Flow pS - LTM-0.56
Earnings pS (EPS)-0.63
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin0.00
Free Cash Flow Margin 5YEAR AVG-1,977.53
Net Profit Margin0.0
Net Profit Margin - 5YEAR AVRG.
Equity Productivity0.00
Return on Equity (ROE)-0.5
Return on Equity (ROE) - 5YEAR AVRG.-1.0
Capital Invested Productivity0.00
Return on Capital Invested (ROCI)-0.9
Return on Capital Invested (ROCI) - 5YEAR AVRG.-0.9
Assets Productivity0.00
Return on Assets (ROA)-0.5
Return on Assets (ROA) - 5YEAR AVRG.-0.7
Gross Profit Margin0.0
Gross Profit Margin - 5YEAR AVRG.
EBITDA Margin - LTM0.0
EBIT Margin - LTM0.0
Pre-Tax Profit Margin0.0
Pre-Tax Profit Margin - 5YEAR AVRG.
Effective Tax Rate0.0
Effective Tax Rate - 5YEAR AVRG.0.0
EFFICIENCY RATIOS
Cash Conversion Cycle
Revenue per Employee
Net Income per Employee
Average Collection Period
Receivables Turnover0.0
Day's Inventory Turnover Ratio
Inventory Turnover0.0
Inventory/Sales0.0
Accounts Payble/Sales0.00
Assets/Revenue0.00
Net Working Capital Turnover0.00
Fixed Assets Turnover0.00
Total Assets Turnover0.0
Revenue per $ Cash0.00
Revenue per $ Plant0.00
Revenue per $ Common Equity0.00
Revenue per $ Capital Invested0.00
Selling, General & Adm/tive (SG&A) as % of Revenue0.0
SG&A Expense as % of Revenue - 5YEAR AVRG.0.0
Research & Devlopment (R&D) as % of Revenue0.0
R&D Expense as % of Revenue - 5YEAR AVRG.0.0

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq achn140728 20:36